-what is already known
Bladder
cancer is the most common neoplasm of the urinary tract and there are no
effective therapies that delay disease recurrence or drug resistance.
IR-780,a near-infrared fluorescent agent,has been reported to have
both tumor and mitochondrial targeting properties. However, research on
the antitumor effect of IR-780 is limited.